Ontology type: schema:ScholarlyArticle
1995-09
AUTHORSA. Arista, C. Sturiale, P. Riva, V. Tison, M. Frattarelli, G. Moscatelli, G. Franceschi, A. Spinelli
ABSTRACTThe authors report their preliminary experience with the use of radiolabelled monoclonal antibodies (MAb) as an adjuvant treatment for 33 malignant gliomas. MAbs employed in this study are raised against Tenascin (TN) which is an antigen of the extracellular matrix of the tumour. It has also been found in neoplastic cells but never in normal brain tissue. This therapy is aimed to give a local high dose radiation (boost) while sparing healthy brain structures.This treatment has always been well tolerated and no adverse reactions at the level of CNS or major extraneural organs has been observed. Significant improvement of median survival has been obtained but this result should be cautiously evaluate since the study is non-randomized. Comparison with other current adjuvant technique is briefly discussed. More... »
PAGES159-162
http://scigraph.springernature.com/pub.10.1007/bf02187762
DOIhttp://dx.doi.org/10.1007/bf02187762
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1042591080
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/8748808
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Adult",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antibodies, Monoclonal",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Astrocytoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Brain",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Brain Neoplasms",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Combined Modality Therapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Diagnostic Imaging",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Follow-Up Studies",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glioblastoma",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Injections, Intralesional",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Iodine Radioisotopes",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Male",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Middle Aged",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplasm, Residual",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Radioimmunotherapy",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Radiotherapy, Adjuvant",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Tenascin",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Treatment Outcome",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Neurosurgery Department, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Neurosurgery Department, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Arista",
"givenName": "A.",
"id": "sg:person.0722464216.62",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0722464216.62"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Neurosurgery Department, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Neurosurgery Department, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Sturiale",
"givenName": "C.",
"id": "sg:person.0707212772.14",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0707212772.14"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Riva",
"givenName": "P.",
"id": "sg:person.01177547630.17",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01177547630.17"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Pathology Service \u201cM. Bufalini\u201d, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/grid.414682.d",
"name": [
"Pathology Service \u201cM. Bufalini\u201d, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Tison",
"givenName": "V.",
"id": "sg:person.01255126264.90",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01255126264.90"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Neurosurgery Department, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Neurosurgery Department, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Frattarelli",
"givenName": "M.",
"id": "sg:person.01322326452.21",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01322326452.21"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Moscatelli",
"givenName": "G.",
"id": "sg:person.01212250304.38",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01212250304.38"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Franceschi",
"givenName": "G.",
"id": "sg:person.01371354664.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01371354664.54"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy",
"id": "http://www.grid.ac/institutes/None",
"name": [
"Nuclear Medicine Department and Istituto Oncologico Romagnolo, Hospital Cesena, Italy"
],
"type": "Organization"
},
"familyName": "Spinelli",
"givenName": "A.",
"id": "sg:person.01105600202.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01105600202.52"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1007/bf00263810",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022848260",
"https://doi.org/10.1007/bf00263810"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-7091-6672-7_2",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1042312345",
"https://doi.org/10.1007/978-3-7091-6672-7_2"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/256495a0",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1001387921",
"https://doi.org/10.1038/256495a0"
],
"type": "CreativeWork"
}
],
"datePublished": "1995-09",
"datePublishedReg": "1995-09-01",
"description": "The authors report their preliminary experience with the use of radiolabelled monoclonal antibodies (MAb) as an adjuvant treatment for 33 malignant gliomas. MAbs employed in this study are raised against Tenascin (TN) which is an antigen of the extracellular matrix of the tumour. It has also been found in neoplastic cells but never in normal brain tissue. This therapy is aimed to give a local high dose radiation (boost) while sparing healthy brain structures.This treatment has always been well tolerated and no adverse reactions at the level of CNS or major extraneural organs has been observed. Significant improvement of median survival has been obtained but this result should be cautiously evaluate since the study is non-randomized. Comparison with other current adjuvant technique is briefly discussed.",
"genre": "article",
"id": "sg:pub.10.1007/bf02187762",
"inLanguage": "en",
"isAccessibleForFree": false,
"isPartOf": [
{
"id": "sg:journal.1358261",
"issn": [
"0001-6268",
"0942-0940"
],
"name": "Acta Neurochirurgica",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "3-4",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "135"
}
],
"keywords": [
"monoclonal antibodies",
"malignant gliomas",
"current adjuvant techniques",
"radiolabelled monoclonal antibodies",
"high dose radiation",
"normal brain tissue",
"adjuvant treatment",
"median survival",
"intralesional administration",
"adjuvant techniques",
"adverse reactions",
"extraneural organs",
"neoplastic cells",
"preliminary experience",
"brain tissue",
"dose radiation",
"brain structures",
"treatment",
"gliomas",
"antibodies",
"significant improvement",
"tenascin",
"extracellular matrix",
"therapy",
"tumors",
"antigen",
"administration",
"I-131",
"survival",
"study",
"organs",
"tissue",
"cells",
"CN",
"levels",
"levels of CN",
"improvement",
"experience",
"use",
"authors",
"comparison",
"results",
"radiation",
"reaction",
"technique",
"matrix",
"structure",
"local high dose radiation",
"healthy brain structures",
"major extraneural organs"
],
"name": "Intralesional administration of I-131 labelled monoclonal antibodies in the treatment of malignant gliomas",
"pagination": "159-162",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1042591080"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1007/bf02187762"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"8748808"
]
}
],
"sameAs": [
"https://doi.org/10.1007/bf02187762",
"https://app.dimensions.ai/details/publication/pub.1042591080"
],
"sdDataset": "articles",
"sdDatePublished": "2022-01-01T18:07",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_280.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1007/bf02187762"
}
]Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/bf02187762'
This table displays all metadata directly associated to this object as RDF triples.
262 TRIPLES
22 PREDICATES
101 URIs
90 LITERALS
28 BLANK NODES